| Variables |
AHR |
P-value |
95% CI |
| Sex |
| Female |
Reference |
|
|
| Male |
2.73 |
0.007 |
1.31,5.66 |
| TB-smear |
| Negative |
Reference |
|
|
| Positive |
2.05 |
0.04 |
1.02,4.12 |
| Undetermined |
1.45 |
0.32 |
0.64,4.44 |
| Regimen |
| d4t (30)-3TC-NVP |
Reference |
|
|
| d4t (40)-3TC-NVP |
0.63 |
0.34 |
0.25,1.63 |
| d4t (30)-3TC-EFV |
0.83 |
0.69 |
0.34,2.04 |
| d4t (40)-3TC-EFV |
1.8 |
0.18 |
0.75,4.32 |
| AZT-3TC-NVP |
3.47 |
0.04 |
1.02,11.83 |
| AZT-3TC-EFV |
1.57 |
0.23 |
0.85,6.46 |
| Functional status |
| Working |
Reference |
|
|
| Ambulatory |
1.66 |
0.11 |
0.88,3.12 |
| Bedridden |
1.03 |
0.96 |
0.33,3.24 |
| CD4cat1 (cells/mm3) |
| <50 |
Reference |
|
|
| 50-100 |
0.84 |
0.67 |
0.38,1.87 |
| 101-200 |
0.71 |
0.4 |
0.33,1.56 |
| >200 |
1.15 |
0.74 |
0.49,2.68 |
| Weight (Kg.) |
| ≤40 |
Reference |
|
|
| 40-50 |
0.74 |
0.44 |
0.34,1.58 |
| 50-60 |
0.6 |
0.26 |
0.25,1.46 |
| >60 |
0.24 |
0.046* |
0.06,0.96 |
| Hemoglobin(g/dl) |
| Anemic |
Reference |
|
|
| Normal |
0.49 |
0.054 |
1.02,4.12 |
|
